1. Wu JC, Chen YC, Liu L, et al. Effects of age, gender, and socio-economic status on the incidence of spinal cord injury: an assessment using the eleven-year comprehensive nationwide database of Taiwan. J Neurotrauma 2012 29:889-97.
3. Chen HY, Chiu WT, Chen SS, et al. A nationwide epidemiological study of spinal cord injuries in Taiwan from July 1992 to June 1996. Neurol Res 1997 19:617-22.
5. Jansen O, Grasmuecke D, Meindl RC, et al. Hybrid assistive limb exoskeleton HAL in the rehabilitation of chronic spinal cord injury: proof of concept; the results in 21 patients. World Neurosurg 2018 110:e73-8.
6. Aach M, Cruciger O, Sczesny-Kaiser M, et al. Voluntary driven exoskeleton as a new tool for rehabilitation in chronic spinal cord injury: a pilot study. Spine J 2014 14:2847-53.
8. Torregrosa T, Koppes RA. Bioelectric medicine and devices for the treatment of spinal cord injury. Cells Tissues Organs 2016 202:6-22.
9. Dalamagkas K, Tsintou M, Seifalian A, et al. Translational regenerative therapies for chronic spinal cord injury. Int J Mol Sci 2018 19(6):pii: E1776.
https://doi.org/10.3390/ijms19061776.
14. Vaquero J, Zurita M, Rico MA, et al. An approach to personalized cell therapy in chronic complete paraplegia: the Puerta de Hierro phase I/II clinical trial. Cytotherapy 2016 18:1025-36.
19. Tabakow P, Jarmundowicz W, Czapiga B, et al. Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant 2013 22:1591-612.
20. Saberi H, Moshayedi P, Aghayan HR, et al. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes. Neurosci Lett 2008 443:46-50.
22. Derakhshanrad N, Saberi H, Shafiee S, et al. Safety of intramedullary autologous peripheral nerve grafts for post-rehabilitated complete motor spinal cord injuries: a phase I study. Acta Med Iran 2013 51:842-54.
23. Kucher K, Johns D, Maier D, et al. First-in-man intrathecal application of neurite growth-promoting anti-Nogo-A antibodies in acute spinal cord injury. Neurorehabil Neural Repair 2018 32:578-89.
24. Wu JC, Huang WC, Tsai YA, et al. Nerve repair using acidic fibroblast growth factor in human cervical spinal cord injury: a preliminary Phase I clinical study. J Neurosurg Spine 2008 8:208-14.
25. Wu JC, Huang WC, Chen YC, et al. Acidic fibroblast growth factor for repair of human spinal cord injury: a clinical trial. J Neurosurg Spine 2011 15:216-27.
27. Derakhshanrad N, Saberi H, Yekaninejad MS, et al. Safety of granulocyte colony-stimulating factor (G-CSF) administration for postrehabilitated motor complete spinal cord injury patients: an open-label, phase I study. Cell Transplant 2013 22 Suppl 1:S139-46.
28. Saberi H, Derakhshanrad N, Yekaninejad MS. Comparison of neurological and functional outcomes after administration of granulocyte-colony-stimulating factor in motor-complete versus motor-incomplete postrehabilitated, chronic spinal cord injuries: a phase I/II study. Cell Transplant 2014 23 Suppl 1:S19-23.
29. Derakhshanrad N, Saberi H, Yekaninejad MS, et al. Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial. J Neurosurg Spine 2018 29:97-107.
30. Inada T, Takahashi H, Yamazaki M, et al. Multicenter prospective nonrandomized controlled clinical trial to prove neurotherapeutic effects of granulocyte colony-stimulating factor for acute spinal cord injury: analyses of follow-up cases after at least 1 year. Spine (Phila Pa 1976) 2014 39:213-9.
31. Ray WZ, Mackinnon SE. Management of nerve gaps: autografts, allografts, nerve transfers, and end-to-side neurorrhaphy. Exp Neurol 2010 223:77-85.
32. Borisoff JF, Chan CC, Hiebert GW, et al. Suppression of Rhokinase activity promotes axonal growth on inhibitory CNS substrates. Mol Cell Neurosci 2003 22:405-16.
33. Jain A, Brady-Kalnay SM, Bellamkonda RV. Modulation of Rho GTPase activity alleviates chondroitin sulfate proteoglycan-dependent inhibition of neurite extension. J Neurosci Res 2004 77:299-307.
37. Lee HJ, Bian S, Jakovcevski I, et al. Delayed applications of L1 and chondroitinase ABC promote recovery after spinal cord injury. J Neurotrauma 2012 29:1850-63.
38. Raspa A, Bolla E, Cuscona C, et al. Feasible stabilization of chondroitinase abc enables reduced astrogliosis in a chronic model of spinal cord injury. CNS Neurosci Ther 2019 25:86-100.
39. Keefe KM, Sheikh IS, Smith GM. Targeting neurotrophins to specific populations of neurons: NGF, BDNF, and NT-3 and their relevance for treatment of spinal cord injury. Int J Mol Sci 2017 18(3):pii: E548.
https://doi.org/10.3390/ijms18030548.
40. Mocchetti I, Wrathall JR. Neurotrophic factors in central nervous system trauma. J Neurotrauma 1995 12:853-70.
44. Gospodarowicz D. Purification of a fibroblast growth factor from bovine pituitary. J Biol Chem 1975 250:2515-20.
45. Gambarini AG, Armelin HA. Purification and partial characterization of an acidic fibroblast growth factor from bovine pituitary. J Biol Chem 1982 257:9692-7.
47. Harvey AR, Lovett SJ, Majda BT, et al. Neurotrophic factors for spinal cord repair: Which, where, how and when to apply, and for what period of time? Brain Res 2015 1619:36-71.
50. Rubin JS, Bottaro DP, Chedid M, et al. Keratinocyte growth factor. Cell Biol Int 1995 19:399-411.
52. Laird JM, Mason GS, Thomas KA, et al. Acidic fibroblast growth factor stimulates motor and sensory axon regeneration after sciatic nerve crush in the rat. Neuroscience 1995 65:209-16.
54. Haynes LW. Fibroblast (heparin-binding) growing factors in neuronal development and repair. Mol Neurobiol 1988 2:263-89.
55. Cordeiro PG, Seckel BR, Lipton SA, et al. Acidic fibroblast growth factor enhances peripheral nerve regeneration in vivo. Plast Reconstr Surg 1989 83:1013-9.
56. Walter MA, Kurouglu R, Caulfield JB, et al. Enhanced peripheral nerve regeneration by acidic fibroblast growth factor. Lymphokine Cytokine Res 1993 12:135-41.
57. Tsai PY, Cheng H, Huang WC, et al. Outcomes of common peroneal nerve lesions after surgical repair with acidic fibroblast growth factor. J Trauma 2009 66:1379-84.
58. Cheng H, Cao Y, Olson L. Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function. Science 1996 273:510-3.
59. Lee YS, Hsiao I, Lin VW. Peripheral nerve grafts and aFGF restore partial hindlimb function in adult paraplegic rats. J Neurotrauma 2002 19:1203-16.
60. Tsai EC, Krassioukov AV, Tator CH. Corticospinal regeneration into lumbar grey matter correlates with locomotor recovery after complete spinal cord transection and repair with peripheral nerve grafts, fibroblast growth factor 1, fibrin glue, and spinal fusion. J Neuropathol Exp Neurol 2005 64:230-44.
61. Lee YS, Lin CY, Robertson RT, et al. Motor recovery and anatomical evidence of axonal regrowth in spinal cord-repaired adult rats. J Neuropathol Exp Neurol 2004 63:233-45.
62. Lin YL, Chang KT, Lin CT, et al. Repairing the ventral root is sufficient for simultaneous motor and sensory recovery in multiple complete cervical root transection injuries. Life Sci 2014 109:44-9.
63. Nordblom J, Persson JK, Aberg J, et al. FGF1 containing biodegradable device with peripheral nerve grafts induces corticospinal tract regeneration and motor evoked potentials after spinal cord resection. Restor Neurol Neurosci 2012 30:91-102.
64. Lee MJ, Chen CJ, Huang WC, et al. Regulation of chondroitin sulphate proteoglycan and reactive gliosis after spinal cord transection: effects of peripheral nerve graft and fibroblast growth factor 1. Neuropathol Appl Neurobiol 2011 37:585-99.
68. Lee MJ, Chen CJ, Cheng CH, et al. Combined treatment using peripheral nerve graft and FGF-1: changes to the glial environment and differential macrophage reaction in a complete transected spinal cord. Neurosci Lett 2008 433:163-9.
69. Huang MC, Chang PT, Tsai MJ, et al. Sensory and motor recovery after repairing transected cervical roots. Surg Neurol 2007 68 Suppl 1:S17-24.
70. Kuo HS, Tsai MJ, Huang MC, et al. The combination of peripheral nerve grafts and acidic fibroblast growth factor enhances arginase I and polyamine spermine expression in transected rat spinal cords. Biochem Biophys Res Commun 2007 357:1-7.
71. Lee LM, Huang MC, Chuang TY, et al. Acidic FGF enhances functional regeneration of adult dorsal roots. Life Sci 2004 74:1937-43.
72. Huang MC, Chen KC, Chuang TY, et al. Cervical root repair in adult rats after transection: recovery of forelimb motor function. Exp Neurol 2003 180:101-9.
73. Chuang TY, Huang MC, Chen KC, et al. Forelimb muscle activity following nerve graft repair of ventral roots in the rat cervical spinal cord. Life Sci 2002 71:487-96.
74. Cheng H, Liao KK, Liao SF, et al. Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia. Spine (Phila Pa 1976) 2004 29:E284-8.
75. Wu JC, Huang WC, Huang MC, et al. A novel strategy for repairing preganglionic cervical root avulsion in brachial plexus injury by sural nerve grafting. J Neurosurg 2009 110:775-85.
76. Tsai MJ, Tsai SK, Huang MC, et al. Acidic FGF promotes neurite outgrowth of cortical neurons and improves neuroprotective effect in a cerebral ischemic rat model. Neuroscience 2015 305:238-47.
77. Wei X, He S, Wang Z, et al. Fibroblast growth factor 1attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of Parkinson’s disease. Am J Transl Res 2014 6:664-77.
79. Wu F, Chen Z, Tang C, et al. Acid fibroblast growth factor preserves blood-brain barrier integrity by activating the PI3KAkt-Rac1 pathway and inhibiting RhoA following traumatic brain injury. Am J Transl Res 2017 9:910-25.
80. Klingenberg O, Wiedocha A, Citores L, et al. Requirement of phosphatidylinositol 3-kinase activity for translocation of exogenous aFGF to the cytosol and nucleus. J Biol Chem 2000 275:11972-80.
81. Peltier J, O’Neill A, Schaffer DV. PI3K/Akt and CREB regulate adult neural hippocampal progenitor proliferation and differentiation. Dev Neurobiol 2007 67:1348-61.